These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 9506832

  • 1. Thrombopoietin stimulates VEGF release from c-Mpl-expressing cell lines and haematopoietic progenitors.
    Bobik R, Hong Y, Breier G, Martin JF, Erusalimsky JD.
    FEBS Lett; 1998 Feb 13; 423(1):10-4. PubMed ID: 9506832
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.
    Goncalves F, Lacout C, Féger F, Cohen-Solal K, Guichard J, Cramer E, Vainchenker W, Duménil D.
    Leukemia; 1998 Sep 13; 12(9):1355-66. PubMed ID: 9737683
    [Abstract] [Full Text] [Related]

  • 3. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation.
    Madoiwa S, Komatsu N, Mimuro J, Kimura K, Matsuda M, Sakata Y.
    Blood; 1999 Jul 15; 94(2):475-82. PubMed ID: 10397715
    [Abstract] [Full Text] [Related]

  • 4. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
    Goncalves F, Lacout C, Villeval JL, Wendling F, Vainchenker W, Dumenil D.
    Blood; 1997 May 15; 89(10):3544-53. PubMed ID: 9160659
    [Abstract] [Full Text] [Related]

  • 5. Protein kinase C mediates the mitogenic action of thrombopoietin in c-Mpl-expressing UT-7 cells.
    Hong Y, Dumènil D, van der Loo B, Goncalves F, Vainchenker W, Erusalimsky JD.
    Blood; 1998 Feb 01; 91(3):813-22. PubMed ID: 9446641
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
    Majka M, Ratajczak J, Villaire G, Kubiczek K, Marquez LA, Janowska-Wieczorek A, Ratajczak MZ.
    Exp Hematol; 2002 Jul 01; 30(7):751-60. PubMed ID: 12135673
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cytosolic Ca(2+) levels and DNA synthesis of human umbilical vein endothelial cell cultures are unresponsive to thrombopoietin treatment.
    Metzen E, Giesen G, Fandrey J, Jelkmann W.
    Cell Physiol Biochem; 2001 Jul 01; 11(4):197-202. PubMed ID: 11509827
    [Abstract] [Full Text] [Related]

  • 15. Thrombopoietin activates a STAT5-like factor in hematopoietic cells.
    Pallard C, Gouilleux F, Bénit L, Cocault L, Souyri M, Levy D, Groner B, Gisselbrecht S, Dusanter-Fourt I.
    EMBO J; 1995 Jun 15; 14(12):2847-56. PubMed ID: 7796811
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
    Drexler HG, Quentmeier H.
    Hum Cell; 1996 Dec 15; 9(4):309-16. PubMed ID: 9183663
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.